Company / Return on Assets (ROA)
Veracyte, Inc. Return on Assets (ROA) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
4.7%
FY2025
5-year range
-6.7% / 4.7%
FY2021-FY2025
Trend
+153.8%
vs FY2024
Sector context
#52 of 158
Health Care
What the data says
At 4.7%, Veracyte, Inc.'s return on assets (roa) ranks #52 of 158 in the Health Care sector. Return on Assets (ROA) has fluctuated over the past 8 years, ranging from -19.1% in FY2018 to 4.7% in FY2025.
Based on SEC 10-K filings.
4.7% in FY2025 with a 5-year CAGR of +12.4%.
Improved from -6.7% to 4.7% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +7.9pp
- 5-Year Change
- +12.4pp
- 10-Year Change
- -
Sector benchmark
#52 of 158 in Health CareTop 33% of 158This company 4.7% Sector average -2.2%
▼
+315.3% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 153.8% year-over-year.
- Currently 6.9pp above the Health Care sector average.
- Lowest return on assets (roa) in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 4.7% | +153.8% |
| FY2024 | 1.9% | +127.9% |
| FY2023 | -6.7% | -111.1% |
| FY2022 | -3.2% | +50.3% |
| FY2021 | -6.4% | +16.8% |
| FY2020 | -7.6% | -66.8% |
| FY2019 | -4.6% | +76.0% |
| FY2018 | -19.1% | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026